I just finished listening to Prof. Carricks presentation. I...

I just finished listening to Prof. Carricks presentation. I would suggest that anyone who has sold yesterday or today has not listened to this. The study will be presented at the world congress of autism in a couple of months and every concern regarding the trial set up, drop out rates and clinical significance was dispelled by Carrick. In short, the researchers were "over the moon" at the results, as they originally did not expect to find the device to have such a profound impact in the active arm.
This stock will re rate at some time soon and my original goal of 50cents plus still stands after hearing the presentation. For any investor, I highly recommend listening to the full presentation.